-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In an effort to
the Chinese market, a global premix supplier based in Israel has signed a distribution agreement to
into the local food production market.Lyco Red
announced this week that it has
millions
with Shanghai-based Lithy Foods. Shanghai
Lithy
is the national general agent for plant extracts and nutritional supplements.told Food Navigation Asia that the two companies reached an agreement in early September that they would be operational immediately.all this comes after
LycoRed
opened a premix factory in Changzhou, China, which processes infant formula, beverages, baby food and other foods in the Asia Pacific region.time,
Milo Shen
, sales manager for
LycoRed
China, told Asia Food Navigation that the company was targeting the infant food, dairy and supplements markets.Milo Shen
said:
"
opportunity stems from a growing Chinese of mouthfuls and a growing public awareness of nutritional intake.
"
that the company has started projects based on consumers.Lithy
's large networkUnder the agreement, Shanghai
Lithy
Foods will introduce its existing distribution channels to
LycoRed
in China's healthcare products industry and will focus on key market segments for
LycoRed
.A LycoRed
spokesman added that it was easy to choose to work with Shanghai
Lithy
because the Chinese company has extensive experience in developing and expanding the Chinese market through numerous collaborations with international functional ingredient suppliers.
they have developed their own unique business and network model, spanning north and south of China, to ensure that the future
LycoRed
is widely recognized,
"
said, noting that domestic pharmaceutical brands also prefer
Lithy
.about deeper, not just a distribution agreement, he stressed that
Lithy
has the ability to build deep relationships with end-product customers.
"
therefore, this transaction is based not only on marketing and sales, but also on the basis of research and
"
., however, the spokesman noted the larger challenges facing the company, including a lack of consumer awareness
LycoRed
Lyco Red products.